Smecta Strawberry powder for oral suspension in sachets of 3 g 12 pcs

• 1 bag contains diosmectite (dioctahedral smectite) 3 g;
• auxiliary substances: glucose monohydrate, sodium saccharin, strawberry flavoring (maltodextrin, propylene glycol, gum arabic, a mixture of natural and synthetic flavorings).

Hypersensitivity to diosmectite or any of the excipients listed in the Composition section.

Doses

Treatment of acute diarrhea

Children over 2 years of age: 4 sachets per day for 3 days, then 2 sachets per day for 4 days.

Adults: 3 sachets per day for 7 days. If necessary, the dose of the drug can be doubled at the beginning of treatment.

Other indications

Adults: an average of 9 g (3 sachets) per day.

For oral use.

The contents of the sachet must be mixed to form a suspension immediately before use.

For children, the contents of the sachet can be mixed in a 50 ml bottle of water to be used at intervals throughout the day or mixed well with semi-liquid food such as broth, compote, puree, baby food, etc.

For adults, the contents of the sachet can be mixed with half a glass of water.

Diosmectite should be used with caution in patients with a history of severe chronic constipation.

The use of Smecta Orange-Vanilla in infants and children under 2 years of age should be avoided. The benchmark for treatment of acute diarrhea is oral rehydration solution (OR).

In children aged 2 years and older, acute diarrhea should be treated in combination with early use of an oral rehydration solution (OR) to prevent dehydration. Chronic use of Smecta Strawberry should be avoided.

In adults, treatment does not exclude rehydration if necessary.

The volume of rehydration using a solution for oral rehydration or intravenous rehydration depends on the intensity of diarrhea, the age of the patient and the characteristics of the course of the disease.

pregnant

It is not recommended to use Smekta Strawberry during pregnancy.

Children

To be used for the treatment of children aged 2 years and older.

Drivers

Studies of the ability to drive vehicles and work with other mechanisms under the influence of this medicine have not been conducted. However, its impact is expected to be negligible or absent.

An overdose can lead to severe constipation or the formation of a bezoar.

From the gastrointestinal tract: constipation, vomiting.

From the side of the skin and subcutaneous tissue: rash, urticaria, angioedema, itching.

From the side of the immune system: hypersensitivity.

No special storage conditions are required. Keep out of the reach of children.